Add to Calendar 3/27/2019 8:15:00 AM 3/28/2019 2:30:00 PM 2019 Annual Meeting: State of Possible Conference
This year’s Annual Meeting is now the State of Possible Conference where we'll celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks, inspiring and engaging content in the style of a TED Talk. We'll also have a networking reception, the State of Possible Celebration, immediately following Day 1 of the conference, where we'll have great food, drinks, a DJ. Attendees will also have access to the exhibits at the Museum of Science. Join us as we celebrate the State of Possible!
 

If you haven’t attended our Annual Meeting before, it is the premier east coast life sciences conference and this year’s event is better than ever. With speakers like Katrine Bosley, John Maraganore, Jeremy Levin, George Church, and more, we have some of the brightest names in biotech talking about the issues impacting our industry. See our incredible lineup of speakers and topics below. Online registration closes at noon on Tuesday, March 26th. Walk-in registrations will be available on-site. 

 Royal Sonesta Boston, 40 Edwin Land Blvd Cambridge MA 02142
Senior Managing Partner, Pfizer Ventures; Vice President, Pfizer Inc
Barbara has led the Pfizer Ventures since joining Pfizer in 2007. The venture team has invested in 65 companies and ten funds pursuing products, technologies and services, relevant to all aspects of Pfizer’s business, since inception in 2004. The team has been successful in fulfilling their goal of providing financial and strategic returns to Pfizer. Her pharmaceutical career started in the immunology division of Smith Kline & French Research Laboratories. She started venture investing in 1993 when she joined their venture capital group, S.R. One, Limited. Barbara received her undergraduate degree from Penn State and Ph.D. from the Medical College of Pennsylvania (now Drexel University School of Medicine.)

Brought to you by